About 9 Trademarks found that are owned by Zynerba Pharmaceuticals Inc.

The mark consists of the letter "Z" with a partial circle crossing through the "Z".

Pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic drug research and development

Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, autism, auditory diseases and disorders, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, central nervous system diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, fragile x syndrome, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech diseases and disorders, and viral diseases and disorders

Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder; all of the foregoing specifically excluding narcolepsy and management of sleep disorders

The color(s) purple, yellow, orange and red is/are claimed as a feature of the mark.

The color(s) purple, yellow, orange and red is/are claimed as a feature of the mark.

Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, autism, auditory diseases and disorders, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, central nervous system diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, fragile x syndrome, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech diseases and disorders, and viral diseases and disorders

Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder; all of the foregoing specifically excluding narcolepsy and management of sleep disorders

Pharmaceutical preparations, both prescription and over-the-counter, for human and animal use, namely, analgesics, anti-inflammatories, antiarthritic preparations, preparations for treating nausea and vertigo, preparations for the relief of pain and skin irritations, pharmaceutical preparations for enhancing topical penetration of drug delivery through the skin and mucous membranes; tranquilizers and psychotropics; medicated skin care preparations, namely, medicated skin creams, gels, antibiotic ointments and lotions for human and animal use; cleansing solutions for medical use, transdermal patches for use in the treatment of alcoholism, Alzheimer's disease, anorexia, anxiety disorders, appetite modulation, arthritis, cachexia, depression, drug addiction, inflammation, multiple sclerosis, neuralgia, neuropathic pain, obesity, opiate dependence, osteo-arthritis, pain, postsurgical pain, postherpetic neuralgia, seizure disorders, sleep disorders, and cerebrovascular disease; pharmaceutical preparations for the treatment of pain, substance addiction, substance abuse, muscle spasms, treatment of alcoholism, and treatment of neurodegeneration; veterinary products, namely, topical medicated treatments, namely, ointments, creams, solutions, gels, patches, poultices, and plasters for use in the relief of inflammation, arthritis, muscle spasms, pain, dermatitis and skin irritations; veterinary products, namely, pharmaceutical preparations for treating nausea and vertigo, cleansing solutions for medical use, transdermal patches for use in the treatment of anxiety disorders, appetite modulation, cachexia, depression, neuralgia, neuropathic pain, obesity, postsurgical pain, seizure disorders, sleep disorders, and cerebrovascular disease; veterinary dermal and transdermal devices, namely, microneedles sold filled with medication for the treatment of anxiety disorders, appetite modulation, cachexia, depression, neuralgia, neuropathic pain, obesity, postsurgical pain, seizure disorders, sleep disorders, and cerebrovascular disease, and for use in the relief of inflammation, arthritis, muscle spasms, pain, osteoarthritis pain, dermatitis and skin inflammation

Chemicals for use in the manufacture of pharmaceuticals